ArticleOncology letters2019

Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital.

Wei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.